Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 08, 2022 09:30 ET | Source: AVX Corporation

KYOCERA AVX IS EXHIBITING AT ELECTRONICA 2022

FOUNTAIN INN, S.C., Nov. 08, 2022 (GLOBE NEWSWIRE) -- KYOCERA AVX, a leading global manufacturer of advanced electronic components engineered to accelerate technological innovation and build a...
November 08, 2022 08:30 ET | Source: SAB Biotherapeutics, Inc.

SAB Biotherapeutics Presents ‘Novel Biologic Therapeutics for Infectious Diseases’ at U.S. Pharma Partnering Summit 2022

SIOUX FALLS, S.D., Nov. 08, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), ("SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces...
November 08, 2022 08:00 ET | Source: PepGen, Inc

PepGen to Participate in the Stifel 2022 Healthcare Conference

BOSTON, Nov. 08, 2022 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming...
November 08, 2022 08:00 ET | Source: Mersana Therapeutics, Inc.

Mersana Therapeutics to Present at Jefferies London Healthcare Conference

CAMBRIDGE, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of...
November 08, 2022 07:30 ET | Source: Repligen Corporation

Repligen Corporation to Present at Upcoming Investor Conferences

WALTHAM, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at...
November 08, 2022 07:00 ET | Source: Eliem Therapeutics, Inc.

Eliem Therapeutics to Participate at Two Upcoming Investor Conferences

SEATTLE and CAMBRIDGE, United Kingdom, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc., a clinical-stage biotechnology company focused on developing novel therapies for neuronal...
November 07, 2022 17:00 ET | Source: Bombardier Inc.

Le stimulant séminaire annuel Safety Standdown de Bombardier a lieu pour une 26e année à Wichita afin d’explorer comment l’industrie de l’aviation « fait progresser la sécurité »

Cet événement phare sur la sécurité fait la promotion de l’apprentissage continu pour mettre en lumière les plus récentes connaissances en la matière disponibles dans toute l’industriePrès de...
November 07, 2022 17:00 ET | Source: Bombardier Inc.

Bombardier’s Engaging 26th Annual Safety Standdown Conference Returns to Wichita to Explore How the Aviation Industry is “Moving Safety Forward”

Prominent safety event promotes lifelong learning to highlight the latest safety knowledge available throughout the industryClose to 400 aviation professionals are expected to attend the event with...
November 07, 2022 09:37 ET | Source: All Day DevOps

2022 All Day DevOps Conference Kicks Off with Schedule Release

Fulton, Md., Nov. 07, 2022 (GLOBE NEWSWIRE) -- All Day DevOps, the largest conference in the world dedicated to sharing DevOps best practices, today announced its full 2022 schedule. Packed with...
November 07, 2022 08:35 ET | Source: Virtual Investor Conferences

Anfield Energy, Inc. to Webcast Live at VirtualInvestorConferences.com November 8th

VANCOUVER, British Columbia, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Anfield Energy, Inc. (TSXV: AEC; OTCQB: ANLDF) is a uranium and vanadium developer with all of its assets in the U.S. Anfield’s current...